Pharmaceutical Litigation Attorneys
What is Zostavax?
Zostavax is a single-injection vaccine against shingles and contains the live chickenpox (
herpes zoster) virus. The vaccine is approximately about fourteen times stronger than the chickenpox vaccine given to children. It is also an expensive shot and only prevents shingles in about 50% of patients.
Zostavax Side Effects
Ironically potential Zostavax side effects includes shingles, the very same disease it is supposed to prevent, and chickenpox. Both of these illnesses can have serious health complications. The Food and Drug Administration (FDA) requested that Merck add "shingles" to the possible side effects from Zostavax. Zostavax injuries can be long-term and include stroke, lupus, meningitis, and other serious health conditions.
What is Shingles?
Shingles is a painful skin rash that occurs when the virus that causes chickenpox is re-activated. It can cause blindness and excruciating chronic pain, especially for the elderly.
ZOSTAVAX LAWSUIT
Napoli Shkolnik PLLC is evaluating claims for a Zostavax Shingles Vaccine lawsuit. In 2006, the FDA approved Zostavax as a vaccine prescription to prevent Shingles for individuals over 50. Studies have now shown that Zostavax can cause a person vaccinated with the drug to get Shingles.
If you have been diagnosed with the Shingles virus after taking Zostavax, we strongly encourage you to contact the experienced
pharmaceutical litigation attorneys at Napoli Shkolnik PLLC for a free, confidential consultation.
April 29, 2026
Copper smelting is a vital industrial process, but it comes with serious environmental and public health risks. Lead contamination from smelting operations has long affected communities across the...
Read the Article
April 22, 2026
Sexual Abuse in Trusted Institutions: Betrayal of Power Sexual abuse is a profound violation of trust, especially when it happens within institutions that are meant to protect and...
Read the Article
April 17, 2026
For years, McKinsey & Company has settled opioid-related claims without ever having to account for its conduct in a courtroom. That is about to change. On March 3,...
Read the Article